SCA
KYTH

SAC Capital Advisors’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

SAC Capital Advisors’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-100,000
Closed -$2.71M – 2082
2013
Q2 		$2.71M Buy
+100,000
New +$2.29M 0.01% 678

Other funds holding KYTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SAC Capital Advisors's KYTH Position: Q3 2013 in Review

SAC Capital Advisors sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q3 2013, closing a stake of 100,000 shares — an estimated $2.71M sold.

SAC Capital Advisors first reported a position in KYTH in Q2 2013 and held it in 1 quarter. The position peaked at $2.71M in Q2 2013. 83 funds tracked by Wall St. Rank hold KYTH as of Q3 2013.

  • SAC Capital Advisors reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q3 2013 after selling out during the quarter.
  • SAC Capital Advisors sold 100,000 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q3 2013, an estimated $2.71M.
  • SAC Capital Advisors first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 1 quarter.
  • SAC Capital Advisors's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $2.71M in Q2 2013.
  • 83 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q3 2013.

Based on SAC Capital Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.